Read More Pharma Industry News NK cell immunotherapy moves toward solid tumors as GT Biopharma files IND for GTB-5550 TriKE Find out how NK cell immunotherapy is moving into solid tumors as GT Biopharma files an IND for its B7-H3-targeted TriKE GTB-5550. bySoujanya RaviJanuary 20, 2026